Sensei shrinks workforce by 65%, terminates 3 executive roles
After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts.
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the...
Sensei Biotherapeutics, Inc. SEC 10-Q Report
Sensei Biotherapeutics, Inc., a biotechnology company focused on developing innovative immunotherapies for cancer patients, has released its...
Sensei Biotherapeutics Reports Q3 2025 Financial Results and Announces Discontinuation of Solnerstotug Development
Sensei Biotherapeutics discontinues solnerstotug development, reviews strategic alternatives, and reduces workforce by 65% amid financial...
Sensei Ag expands U.S greenhouse network with 26-acre acquisition
Sensei Ag recently acquired a 283,000-square-foot greenhouse and research facility on 26-acres of land in Lockhart, Texas.
Sensei Lanai names new resort manager
Lanikai Lindsey returns to Sensei Lanai as resort manager after serving at Four Seasons Resort Maui, bringing 23 years of hospitality...
Kalamazoo’s Sensei Thompson brings home three medals from championships
In his third appearance at the World Karate & Kickboxing Commission championships, the Okinawan Karate Academy instructor won a silver and...
Sensei Biotherapeutics Cuts Losses And Jobs As It Seeks Options
The biotech firm narrowed its quarterly loss and slashed costs while eyeing possible mergers or asset sales to shape its next chapter.
Sensei Biotherapeutics (Nasdaq: SNSE) initiates strategic review, reduces workforce 65%
Sensei Biotherapeutics (Nasdaq: SNSE) reported third quarter 2025 results and strategic changes on Nov 14, 2025.
Sensei Biotherapeutics Reports Strategic Shift in Q3 2025
Sensei Biotherapeutics, Inc. ( ($SNSE) ) has released its Q3 earnings. Here is a breakdown of the information Sensei Biotherapeutics,...
Stats
67304
Rank
2.1K
Points
0
Videos
10
Articles
0
Reviews
0
Comments